Arkolith/Insider Trading/VRDN/Form 4

Fairmount Funds Management LLC

Director, 10% OwnerViridian Therapeutics, Inc.\DE (VRDN) · full profile →Form 4 · filed May 13, 2026
Net Buying
Open-Market Buys
$20.0M
Open-Market Sells
$0
Net Open-Market Flow
$20.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 11, 2026Buy(P)1.2M$17.00$20.0M5.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-060294) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML